Exploring the frontier: promising survival in selected patients after CRS and HIPEC for peritoneal metastases from hepatocellular carcinoma—a systematic review | Synapse
March 3, 2026
Exploring the frontier: promising survival in selected patients after CRS and HIPEC for peritoneal metastases from hepatocellular carcinoma—a systematic review
Puntos clave
Survival is notably improved in selected patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Key evidence shows improved survival rates in patients with peritoneal metastases from hepatocellular carcinoma.
Systematic review of CRS and HIPEC interventions identified significant outcomes across various studies.
Findings may improve clinical decision-making for treating hepatocellular carcinoma with peritoneal metastases.